FDA approves Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
PR Newswire —
Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on treatment**) in the OASIS 4 trial1 1.5 mg starting dose available in early January for $149 per month with savings offers; Wegovy® pill is...